From early prophylaxis to delayed treatment: Establishing the plutonium decorporation activity window of hydroxypyridinonate chelating agents

Por An, Dahlia D., Kullgren, Birgitta, Jarvis, Erin E., Abergel, Rebecca J.
Publicado no Chem Biol Interact (2016)

Dose-Dependent Efficacy and Safety Toxicology of Hydroxypyridinonate Actinide Decorporation Agents in Rodents: Towards a Safe and EffectiveHuman Dosing Regimen

Por Bunin, Deborah I., Chang, Polly Y., Doppalapudi, Rupa S., Riccio, Edward S., An, Dahlia, Jarvis, Erin E., Kullgren, Birgitta, Abergel, Rebecca J.
Publicado em 2013

Biomimetic Actinide Chelators: An Update on the Preclinical Development of the Orally Active Hydroxypyridonate Decorporation Agents 3,4,3-LI(1,2-HOPO) and 5-LIO(Me-3,2-HOPO)

Por Abergel, Rebecca J., Durbin, Patricia W., Kullgren, Birgitta, Ebbe, Shirley N., Xu, Jide, Chang, Polly Y., Bunin, Deborah I., Blakely, Eleanor A., Bjornstad, Kathleen A., Rosen, Chris J., Shuh, David K., Raymond, Kenneth N.
Publicado em 2010